EP3028696 - AGENT FOR ALLEVIATING SIDE EFFECTS IN CANCER CHEMOTHERAPY [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 03.12.2021 Database last updated on 12.11.2024 | |
Former | The patent has been granted Status updated on 25.12.2020 | ||
Former | Grant of patent is intended Status updated on 17.08.2020 | ||
Former | Examination is in progress Status updated on 08.11.2019 | Most recent event Tooltip | 06.09.2024 | Lapse of the patent in a contracting state New state(s): MT | published on 09.10.2024 [2024/41] | Applicant(s) | For all designated states AJINOMOTO CO., INC. 15-1, Kyobashi 1-chome Chuo-ku Tokyo 104-8315 / JP | [2021/03] |
Former [2016/23] | For all designated states Ajinomoto Co., Inc. 15-1, Kyobashi 1-chome Chuo-ku Tokyo 104-8315 / JP | Inventor(s) | 01 /
KURIHARA, Shigekazu c/o AJINOMOTO CO., INC. 1-1, Suzuki-cho Kawasaki-ku Kawasaki-shi Kanagawa 210-8681 / JP | 02 /
TSUCHIYA, Takashi c/o Sendai City Medical Center Sendai Open Hospital 22-1 Tsurugaya 5-chome Miyagino-ku Sendai-shi Miyagi 983-0824 / JP | [2021/04] |
Former [2016/23] | 01 /
KURIHARA, Shigekazu c/o AJINOMOTO CO. INC. 1-1 Suzuki-cho Kawasaki-ku Kawasaki-shi Kanagawa 210-8681 / JP | ||
02 /
TSUCHIYA, Takashi c/o Sendai City Medical Center Sendai Open Hospital 22-1 Tsurugaya 5-chome Miyagino-ku Sendai-shi Miyagi 983-0824 / JP | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [2021/04] |
Former [2016/23] | Nicholls, Kathryn Margaret, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | Application number, filing date | 14831281.2 | 01.07.2014 | [2016/23] | WO2014JP67587 | Priority number, date | JP20130159736 | 31.07.2013 Original published format: JP 2013159736 | [2016/23] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015015989 | Date: | 05.02.2015 | Language: | JA | [2015/05] | Type: | A1 Application with search report | No.: | EP3028696 | Date: | 08.06.2016 | Language: | EN | [2016/23] | Type: | B1 Patent specification | No.: | EP3028696 | Date: | 27.01.2021 | Language: | EN | [2021/04] | Search report(s) | International search report - published on: | JP | 05.02.2015 | (Supplementary) European search report - dispatched on: | EP | 02.01.2017 | Classification | IPC: | A61K31/198, A61P35/00, A61P39/00, A61K9/20, A61P1/02, A61P1/08, A61P1/10, A61P43/00, A61K9/00 | [2020/35] | CPC: |
A61K31/198 (EP,US);
A61K45/06 (US);
A61K9/0053 (EP,US);
A61P1/02 (EP);
A61P1/08 (EP);
A61P1/10 (EP);
A61P35/00 (EP);
A61P39/00 (EP);
A61P43/00 (EP);
A61K9/20 (EP,US)
(-)
| C-Set: |
A61K31/198, A61K2300/00 (EP,US)
|
Former IPC [2017/04] | A61K31/198, A61P35/00, A61P39/00, A61K45/06, A61K9/00, A61K9/20 | ||
Former IPC [2016/23] | A61K31/198, A61P35/00, A61P39/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/23] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | MITTEL ZUR LINDERUNG DER NEBENWIRKUNGEN EINER CHEMOTHERAPIE BEI KREBS | [2016/23] | English: | AGENT FOR ALLEVIATING SIDE EFFECTS IN CANCER CHEMOTHERAPY | [2016/23] | French: | AGENT PERMETTANT D'ATTÉNUER LES EFFETS SECONDAIRES LORS DE TRAITEMENT DU CANCER PAR CHIMIOTHÉRAPIE | [2016/23] | Entry into regional phase | 15.02.2016 | Translation filed | 16.02.2016 | National basic fee paid | 16.02.2016 | Search fee paid | 16.02.2016 | Designation fee(s) paid | 16.02.2016 | Examination fee paid | Examination procedure | 16.02.2016 | Examination requested [2016/23] | 28.07.2017 | Amendment by applicant (claims and/or description) | 13.11.2019 | Despatch of a communication from the examining division (Time limit: M04) | 10.02.2020 | Reply to a communication from the examining division | 18.08.2020 | Communication of intention to grant the patent | 15.12.2020 | Fee for grant paid | 15.12.2020 | Fee for publishing/printing paid | 15.12.2020 | Receipt of the translation of the claim(s) | Opposition(s) | 28.10.2021 | No opposition filed within time limit [2022/01] | Fees paid | Renewal fee | 11.07.2016 | Renewal fee patent year 03 | 12.07.2017 | Renewal fee patent year 04 | 11.07.2018 | Renewal fee patent year 05 | 15.07.2019 | Renewal fee patent year 06 | 14.07.2020 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 01.07.2014 | AL | 27.01.2021 | AT | 27.01.2021 | CY | 27.01.2021 | CZ | 27.01.2021 | DK | 27.01.2021 | EE | 27.01.2021 | ES | 27.01.2021 | FI | 27.01.2021 | HR | 27.01.2021 | IT | 27.01.2021 | LT | 27.01.2021 | LV | 27.01.2021 | MC | 27.01.2021 | MK | 27.01.2021 | MT | 27.01.2021 | NL | 27.01.2021 | PL | 27.01.2021 | RO | 27.01.2021 | RS | 27.01.2021 | SE | 27.01.2021 | SI | 27.01.2021 | SK | 27.01.2021 | SM | 27.01.2021 | TR | 27.01.2021 | BG | 27.04.2021 | NO | 27.04.2021 | GR | 28.04.2021 | IS | 27.05.2021 | PT | 27.05.2021 | IE | 01.07.2021 | LU | 01.07.2021 | BE | 31.07.2021 | CH | 31.07.2021 | LI | 31.07.2021 | [2024/41] |
Former [2024/29] | HU | 01.07.2014 | |
AL | 27.01.2021 | ||
AT | 27.01.2021 | ||
CY | 27.01.2021 | ||
CZ | 27.01.2021 | ||
DK | 27.01.2021 | ||
EE | 27.01.2021 | ||
ES | 27.01.2021 | ||
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
IT | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
MC | 27.01.2021 | ||
MK | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RO | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SI | 27.01.2021 | ||
SK | 27.01.2021 | ||
SM | 27.01.2021 | ||
TR | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
IS | 27.05.2021 | ||
PT | 27.05.2021 | ||
IE | 01.07.2021 | ||
LU | 01.07.2021 | ||
BE | 31.07.2021 | ||
CH | 31.07.2021 | ||
LI | 31.07.2021 | ||
Former [2024/22] | HU | 01.07.2014 | |
AL | 27.01.2021 | ||
AT | 27.01.2021 | ||
CY | 27.01.2021 | ||
CZ | 27.01.2021 | ||
DK | 27.01.2021 | ||
EE | 27.01.2021 | ||
ES | 27.01.2021 | ||
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
IT | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
MC | 27.01.2021 | ||
MK | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RO | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SI | 27.01.2021 | ||
SK | 27.01.2021 | ||
SM | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
IS | 27.05.2021 | ||
PT | 27.05.2021 | ||
IE | 01.07.2021 | ||
LU | 01.07.2021 | ||
BE | 31.07.2021 | ||
CH | 31.07.2021 | ||
LI | 31.07.2021 | ||
Former [2023/30] | HU | 01.07.2014 | |
AL | 27.01.2021 | ||
AT | 27.01.2021 | ||
CY | 27.01.2021 | ||
CZ | 27.01.2021 | ||
DK | 27.01.2021 | ||
EE | 27.01.2021 | ||
ES | 27.01.2021 | ||
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
IT | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
MC | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RO | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SI | 27.01.2021 | ||
SK | 27.01.2021 | ||
SM | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
IS | 27.05.2021 | ||
PT | 27.05.2021 | ||
IE | 01.07.2021 | ||
LU | 01.07.2021 | ||
BE | 31.07.2021 | ||
CH | 31.07.2021 | ||
LI | 31.07.2021 | ||
Former [2023/27] | HU | 01.07.2014 | |
AL | 27.01.2021 | ||
AT | 27.01.2021 | ||
CZ | 27.01.2021 | ||
DK | 27.01.2021 | ||
EE | 27.01.2021 | ||
ES | 27.01.2021 | ||
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
IT | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
MC | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RO | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SI | 27.01.2021 | ||
SK | 27.01.2021 | ||
SM | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
IS | 27.05.2021 | ||
PT | 27.05.2021 | ||
IE | 01.07.2021 | ||
LU | 01.07.2021 | ||
BE | 31.07.2021 | ||
CH | 31.07.2021 | ||
LI | 31.07.2021 | ||
Former [2022/35] | AL | 27.01.2021 | |
AT | 27.01.2021 | ||
CZ | 27.01.2021 | ||
DK | 27.01.2021 | ||
EE | 27.01.2021 | ||
ES | 27.01.2021 | ||
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
IT | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
MC | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RO | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SI | 27.01.2021 | ||
SK | 27.01.2021 | ||
SM | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
IS | 27.05.2021 | ||
PT | 27.05.2021 | ||
IE | 01.07.2021 | ||
LU | 01.07.2021 | ||
BE | 31.07.2021 | ||
CH | 31.07.2021 | ||
LI | 31.07.2021 | ||
Former [2022/34] | AL | 27.01.2021 | |
AT | 27.01.2021 | ||
CZ | 27.01.2021 | ||
DK | 27.01.2021 | ||
EE | 27.01.2021 | ||
ES | 27.01.2021 | ||
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
IT | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
MC | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RO | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SI | 27.01.2021 | ||
SK | 27.01.2021 | ||
SM | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
IS | 27.05.2021 | ||
PT | 27.05.2021 | ||
LU | 01.07.2021 | ||
BE | 31.07.2021 | ||
CH | 31.07.2021 | ||
LI | 31.07.2021 | ||
Former [2022/23] | AL | 27.01.2021 | |
AT | 27.01.2021 | ||
CZ | 27.01.2021 | ||
DK | 27.01.2021 | ||
EE | 27.01.2021 | ||
ES | 27.01.2021 | ||
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
IT | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
MC | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RO | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SI | 27.01.2021 | ||
SK | 27.01.2021 | ||
SM | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
IS | 27.05.2021 | ||
PT | 27.05.2021 | ||
LU | 01.07.2021 | ||
CH | 31.07.2021 | ||
LI | 31.07.2021 | ||
Former [2022/21] | AL | 27.01.2021 | |
AT | 27.01.2021 | ||
CZ | 27.01.2021 | ||
DK | 27.01.2021 | ||
EE | 27.01.2021 | ||
ES | 27.01.2021 | ||
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
MC | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RO | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SI | 27.01.2021 | ||
SK | 27.01.2021 | ||
SM | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
PT | 27.05.2021 | ||
CH | 31.07.2021 | ||
LI | 31.07.2021 | ||
Former [2022/18] | AL | 27.01.2021 | |
AT | 27.01.2021 | ||
CZ | 27.01.2021 | ||
DK | 27.01.2021 | ||
EE | 27.01.2021 | ||
ES | 27.01.2021 | ||
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
MC | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RO | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SI | 27.01.2021 | ||
SK | 27.01.2021 | ||
SM | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
PT | 27.05.2021 | ||
Former [2022/13] | AL | 27.01.2021 | |
AT | 27.01.2021 | ||
CZ | 27.01.2021 | ||
DK | 27.01.2021 | ||
EE | 27.01.2021 | ||
ES | 27.01.2021 | ||
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RO | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SI | 27.01.2021 | ||
SK | 27.01.2021 | ||
SM | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
PT | 27.05.2021 | ||
Former [2022/10] | AL | 27.01.2021 | |
AT | 27.01.2021 | ||
CZ | 27.01.2021 | ||
DK | 27.01.2021 | ||
EE | 27.01.2021 | ||
ES | 27.01.2021 | ||
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RO | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SK | 27.01.2021 | ||
SM | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
PT | 27.05.2021 | ||
Former [2022/07] | AL | 27.01.2021 | |
AT | 27.01.2021 | ||
CZ | 27.01.2021 | ||
DK | 27.01.2021 | ||
EE | 27.01.2021 | ||
ES | 27.01.2021 | ||
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RO | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SK | 27.01.2021 | ||
SM | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
IS | 27.05.2021 | ||
PT | 27.05.2021 | ||
Former [2021/51] | AT | 27.01.2021 | |
CZ | 27.01.2021 | ||
DK | 27.01.2021 | ||
EE | 27.01.2021 | ||
ES | 27.01.2021 | ||
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RO | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SK | 27.01.2021 | ||
SM | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
IS | 27.05.2021 | ||
PT | 27.05.2021 | ||
Former [2021/50] | AT | 27.01.2021 | |
CZ | 27.01.2021 | ||
DK | 27.01.2021 | ||
EE | 27.01.2021 | ||
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RO | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SK | 27.01.2021 | ||
SM | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
IS | 27.05.2021 | ||
PT | 27.05.2021 | ||
Former [2021/49] | AT | 27.01.2021 | |
CZ | 27.01.2021 | ||
DK | 27.01.2021 | ||
EE | 27.01.2021 | ||
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SM | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
IS | 27.05.2021 | ||
PT | 27.05.2021 | ||
Former [2021/48] | AT | 27.01.2021 | |
CZ | 27.01.2021 | ||
EE | 27.01.2021 | ||
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SM | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
IS | 27.05.2021 | ||
PT | 27.05.2021 | ||
Former [2021/46] | AT | 27.01.2021 | |
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
SM | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
IS | 27.05.2021 | ||
PT | 27.05.2021 | ||
Former [2021/42] | AT | 27.01.2021 | |
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
IS | 27.05.2021 | ||
PT | 27.05.2021 | ||
Former [2021/39] | AT | 27.01.2021 | |
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
NL | 27.01.2021 | ||
PL | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
PT | 27.05.2021 | ||
Former [2021/38] | AT | 27.01.2021 | |
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
NL | 27.01.2021 | ||
RS | 27.01.2021 | ||
SE | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
PT | 27.05.2021 | ||
Former [2021/37] | AT | 27.01.2021 | |
FI | 27.01.2021 | ||
HR | 27.01.2021 | ||
LT | 27.01.2021 | ||
LV | 27.01.2021 | ||
NL | 27.01.2021 | ||
RS | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
PT | 27.05.2021 | ||
Former [2021/36] | FI | 27.01.2021 | |
HR | 27.01.2021 | ||
LT | 27.01.2021 | ||
NL | 27.01.2021 | ||
BG | 27.04.2021 | ||
NO | 27.04.2021 | ||
GR | 28.04.2021 | ||
PT | 27.05.2021 | ||
Former [2021/35] | FI | 27.01.2021 | |
HR | 27.01.2021 | ||
LT | 27.01.2021 | ||
NL | 27.01.2021 | ||
NO | 27.04.2021 | ||
PT | 27.05.2021 | ||
Former [2021/34] | FI | 27.01.2021 | |
LT | 27.01.2021 | ||
NL | 27.01.2021 | ||
NO | 27.04.2021 | ||
PT | 27.05.2021 | ||
Former [2021/33] | FI | 27.01.2021 | |
LT | 27.01.2021 | ||
NO | 27.04.2021 | ||
PT | 27.05.2021 | Documents cited: | Search | [X]EP1486208 (AJINOMOTO KK [JP]) [X] 1-4 * the whole document * * paragraph [0015] - paragraph [0016] * * paragraph [0020] - paragraph [0040] * * examples 1-5 * * claims 1-33 *; | [X]EP1767200 (OSAKA PREFECTURE [JP], et al) [X] 1-4 * the whole document * * paragraph [0001] * * paragraph [0005] * * paragraph [0008] - paragraph [0034] * * examples 1-3 * * claims 1-10 *; | [I]US2007141175 (GOSTINE MARK [US], et al) [I] 1-11 * the whole document * * paragraph [0038] - paragraph [0039] * * examples 1,1b,2,2a ** claims 8-10,14,21-22,33 * | International search | [Y]JP2003531164 (OREGON HEALTH & SCIENCE UNIVERSITY); | [Y]JP2004513957 (RX KINETIX, INC.); | [Y]JP2012502997 (NESTEC S.A.); | [Y] - MICHI HATSUNO ET AL., "N-Acetylcysteine ni yoru 5-Fluorouracil Yudosei Kotsuzui Dokusei no Keigen", THE PHARMACEUTICAL SOCIETY OF JAPAN DAI 130 NENKAI YOSHISHU 3, (20100305), page 155, XP008182722 | [Y] - YUKI KANEMATSU ET AL., "1. FOLFOX no Massho Shinkei Shogai ni Taisuru Yobosaku no Jittai Chosa", AICHI PREFECTURAL JOURNAL OF HOSPITAL PHARMACY, (2008), vol. 36, no. 3, pages 47 - 50, XP008182235 | [Y] - YASUYUKI SAZUKA ET AL., "Glutamate Transporter Mediated Increase of Antitumor Activity by Theanine, an Amino Acid in Green Tea", YAKUGAKU ZASSHI, (2002), vol. 122, no. 11, pages 995 - 999, XP008182115 DOI: http://dx.doi.org/10.1248/yakushi.122.995 | [Y] - CHIEKO INOUE ET AL., "Ryokucha Amino San theanine ni yoru Ko-Shuyozai Fukusayo Keigen Mechanism", PROCEEDINGS OF THE JAPANESE CANCER ASSOCIATION, (2004), vol. 63 RD, page 463, XP008183217 | [Y] - YASUYUKI SADZUKA ET AL., "Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance", TOXICOLOGY LETTERS, (2000), vol. 114, pages 155 - 162, XP000925751 DOI: http://dx.doi.org/10.1016/S0378-4274(99)00290-8 | [Y] - TETSURO SHIBAKUSA ET AL., "Shinshu-ka deno Seitai Hanno to Taisha Dotai' Mouse Geka Shujutsu Model ni Okeru Amino San Cystine Theanine Jutsuzen Toyo ni yoru Jutsugo Ika Koshin no Yokusei Koka", THE JAPANESE JOURNAL OF SURGICAL METABOLISM AND NUTRITION, (201302), vol. 47, no. 1, pages 25 - 30, XP008182116 DOI: http://dx.doi.org/10.11638/jssmn.47.1_25 | [Y] - TOMOYUKI MORIYA ET AL., "B. Amino San Toyo ni yoru Taisha Seitai no Shushoku 3. Shinshu-ji no Amino San Toyo: Shitsu to Ryo, Dochira ga Juyo ka?", THE JAPANESE JOURNAL OF SURGICAL METABOLISM AND NUTRITION, (2012), vol. 46, no. 2, pages 41 - 48, XP008182120 DOI: http://dx.doi.org/10.11638/jssmn.47.1_25 | [Y] - SHIGEKAZU KURIHARA ET AL., "Enhancement of Antigen-Specific Immunoglobulin G Production in Mice by Co-Administration of L-Cystine and L- Theanine", JAPANESE SOCIETY OF VETERINARY SCIENCE, (2007), vol. 69, no. 12, pages 1263 - 1270, XP055313174 |